| NCT ID | NCT02864108 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Down Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2016-07 |
| Primary Completion | 2036-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2016-07 with a primary completion date of 2036-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Human Trisome Project will significantly increase the speed of Down syndrome research and the understanding of associated medical conditions. Its biobank will provide de-identified samples to research.
Eligibility Criteria
Inclusion Criteria: Anyone 6 months to 89 years old who: 1. has Down syndrome (any type) 2. does not have Down syndrome Exclusion Criteria: 1. Prisoners 2. Wards of the state
Contact & Investigator
Joaquin Espinosa, PhD
PRINCIPAL INVESTIGATOR
Linda Crnic Institute for Down Syndrome at the University of Colorado Denver
Frequently Asked Questions
Who can join the NCT02864108 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, up to 89 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02864108 currently recruiting?
Yes, NCT02864108 is actively recruiting participants. Contact the research team at dsresearch@cuanschutz.edu for enrollment information.
Where is the NCT02864108 trial being conducted?
This trial is being conducted at Denver, United States.
Who is sponsoring the NCT02864108 clinical trial?
NCT02864108 is sponsored by University of Colorado, Denver. The principal investigator is Joaquin Espinosa, PhD at Linda Crnic Institute for Down Syndrome at the University of Colorado Denver. The trial plans to enroll 2,500 participants.